![Thomas Civik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Civik
Amministratore Delegato presso
PYXIS ONCOLOGY, INC.
Patrimonio netto: 399 395 $ in data 31/05/2026
Profilo
Thomas Civik is Chief Executive Officer & Director at Pyxis Oncology, Inc. since 2026 and Independent Chairman at Imcheck Therapeutics SAS since 2023.
Former roles include President, Chief Executive Officer & Director at Five Prime Therapeutics, Inc. from 2020 to 2021; Independent Chairman at Repare Therapeutics, Inc. from 2021 to 2026; Vice President-Avastin Sales & Marketing at Genentech, Inc. from 2000 to 2017; and Chief Commercial Officer at Foundation Medicine, Inc. from 2017 to 2019.
Education includes undergraduate studies at St. Norbert College, Inc. and an MBA from Kellogg School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 0,35% | 20/04/2026 | 221.886 ( 0,35% ) | 399 395 $ | 31/05/2026 |
Posizioni attive di Thomas Civik
| Società | Posizione | Inizio |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Amministratore Delegato | 03/02/2026 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Presidente | 23/03/2023 |
Precedenti posizioni note di Thomas Civik
| Società | Posizione | Fine |
|---|---|---|
| REPARE THERAPEUTICS INC. | Presidente | 28/01/2026 |
| FIVE PRIME THERAPEUTICS, INC. | Amministratore Delegato | 16/04/2021 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/09/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Vendite & Marketing | 01/11/2017 |
Formazione di Thomas Civik
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
St. Norbert College, Inc.
 St. Norbert College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
